Doctor Care Anywhere Group
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 27 Feb 2026
- Reported shorts
- 8K
- Shares on issue
- 366.642M
Doctor Care Anywhere Group (DOC) financials
Results, ratios and statements
Latest result
12 months to 30 Jun 2026 (TTM Jun 26) vs TTM Jun 25, figures in GBP, the reporting currency
- Revenue
- 39.2Mvs n/a (TTM Jun 25)
- Yahoo Finance, as at 14 Oct 2026
- NPAT
- 1.3Mvs n/a (TTM Jun 25)
- Yahoo Finance, as at 14 Oct 2026
- EPS (diluted)
- 0.003vs −0.009 (TTM Jun 25)
- Yahoo Finance, as at 14 Oct 2026
- Rev YoY
- −3.4%FY
- EPS YoY
- n/aTTM
EPS: prior loss, now profit (growth is not meaningful against a loss).
Summary of Half Yearly Report and Accounts, 17 Aug 2026
Doctor Care Anywhere Group reported revenue of £20.4m for H1 2026, up 6.3% from H1 2025, and net profit of £0.6m, up 28.3%. No interim dividend was declared. The company highlighted continued profit and positive cash generation, with net operating cash flows of £3.8m, and noted the acquisition of a weight management business (DCA Medicspot Ltd) in May 2026, which contributed £0.9m in revenue.
Automated summary of the filing; the filing itself is the record.
Key ratios
12 months to 30 Jun 2026 (TTM); balance sheet at 31 Dec 2025, 6 months before; prices to 14 Oct 2026
- Gross margin
- 32.7%
- Operating margin
- −2.1%
- Net margin
- 3.3%
- FCF margin
- 8.6%
- ROE
- n/a
- ROA
- 8.0%
- FCF conversion
- 2.62×
- Net debt (excl. leases)
- GBP 2.6M
- Net debt / EBITDA
- 0.5×
- Current ratio
- 1.6×
- Interest cover
- −1.0×
- Cash dividends paid / net profit
- n/a
- Market cap
- $42.2M
- P/E
- n/a (reports in GBP)
- P/B
- n/a (reports in GBP)
Ratios use the reporting currency (GBP); market cap is in AUD. Source: Yahoo Finance, as at 14 Oct 2026.
Financial statements
Figures in GBP, the reporting currency; Yahoo Finance unless marked
| Line item | TTM Jun 26 | FY25 | FY24 | FY23 | FY22 |
|---|---|---|---|---|---|
| Revenue | 39.2M | 38.0M | 39.3M | 38.5M | 29.8M |
| Gross profit | 12.8M | 16.4M | 22.4M | 17.7M | 12.8M |
| Operating income | −825.0K | −745.0K | −7.1M | −8.7M | −20.2M |
| EBITDA | 5.0M | 4.4M | −2.1M | −8.4M | −22.2M |
| EBIT | 2.1M | 1.9M | −4.4M | −8.4M | −22.2M |
| Interest expense | 818.0K | 742.0K | 828.0K | 507.0K | 77.0K |
| Pretax income | 1.3M | 1.2M | −5.3M | −8.9M | −22.3M |
| Tax | 1.0K | 49.0K | −135.0K | −695.0K | −257.0K |
| NPAT | 1.3M | 1.2M | −6.3M | −10.0M | −22.0M |
| Net interest income | −801.0K | −722.0K | −713.0K | −459.0K | −75.0K |
| EPS basic | 0.003 | 0.003 | −0.020 | −0.030 | −0.060 |
| EPS diluted | 0.003 | 0.003 | −0.020 | −0.030 | −0.060 |
| Shares | n/a | 366.8M | 366.8M | 366.8M | 366.8M |
Financial reports
The company's own filings, newest first
- Half Yearly Report and AccountsHalf Year Results17 Aug 2026via asx_announcements
- ASX grants relief from quarterly reporting requirementsQuarterly Report20 Jul 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report23 Apr 2026via asx_announcements
- Annual Report to shareholdersAnnual Report26 Mar 2026via asx_announcements
- Preliminary Final ReportAnnual Results25 Feb 2026via asx_announcements
- Preliminary Final Report Release Date AnnouncementAnnual Results19 Feb 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report29 Jan 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report29 Oct 2025via asx_announcements
- Interim Financial Report & Appendix 4DHalf Year Results28 Aug 2025via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report31 Jul 2025via asx_announcements
Showing 10 of 22 reports